Search the Newsreel

Hubbell (NYSE:HUBB) Sales Growth Puts Valuation In The Spotlight

Hubbell (NYSE:HUBB) has reported strong sales growth driven by demand for grid modernization and electrification equipment, leading to updated full-year guidance. While strong operational performance is noted, the company's valuation is under scrutiny, with market expectations already elevated. Future profitability and execution in managing …

Ceribell Wins FDA Nod for AI Tools on Its Neurology Portal

Ceribell has received FDA 510(k) clearances for two AI enhancements integrated into its cloud-based Neurology Portal: Epileptiform Abnormality Detection and Artifact Reduction. These tools aim to improve the diagnosis of epilepsy and streamline the interpretation of EEGs by automatically highlighting abnormal brain wave patterns …

Hubbell Inc $HUBB Shares Bought by Tema ETFs LLC

Tema ETFs LLC increased its stake in Hubbell Inc (NYSE:HUBB) by 44.7% during the second quarter, now owning 52,751 shares valued at $27.599 million. Other institutional investors also adjusted their positions in Hubbell, which has seen varied analyst ratings but holds a consensus "Moderate …

CeriBell Inc (CBLL) Earnings Forecast: Future EPS & Revenue Growth Estimates

Campbell's Co (CPB) Earnings Forecast: Future EPS & Revenue Growth Estimates

Goldfish Are Going Gluten-Free

Campbell's will launch its first certified gluten-free Goldfish crackers nationwide in November, made with a gluten-free flour blend and real cheese. The new product responds to years of consumer requests and aims to boost the company's struggling snacks division. A 5-ounce bag will be …

CeriBell (CBLL) Stock Premium Rides High Margins Despite Deeper Losses

CeriBell (CBLL) stock saw a 10.4% increase after its Q2 earnings report, driven by headline growth in its high-margin medical device business, despite widened net losses. The company reported revenue of US$28.1m and a net loss of US$19.3m, with investors crediting progress in hospital …

Rubellite Energy (TSX:RBY) Stock Rides Profit Rebound As Heavy Oil Risks Persist

Isabella Bank (ISBA) Stock Rides Margin Strength As Valuation Questions Build

Hubbell (HUBB) Reported Strong Sales Growth, Is The Stock Fully Valued?

Hubbell (HUBB) insider plans 547-share stock sale and discloses 2026 vesting

Hubbell Incorporated has filed a Form 144 revealing an insider's plan to sell 547 common shares through Fidelity Brokerage Services LLC. The filing also details future restricted stock vesting awards totaling 547 shares (388 and 159 shares) scheduled for 2026, which are categorized as …

BellRing Brands (BRBR) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 2:00 p.m. ET CALL PARTICIPANTS Investor Relations - Jennifer Meyer President and Chief Executive Officer - Michael Axelrod Chief Financial Officer - Paul Rode Full Conference Call Transcript Operator: Thank you for standing …

Hubbell Inc. stock outperforms competitors on strong trading day

Hubbell Inc. (HUBB) shares rose 2.92% to $519.62 on a generally down day for the stock market, outperforming the S&P 500 Index and Dow Jones Industrial Average. The company's stock closed 8.11% below its 52-week high.

Campbell’s Co. formulates gluten-free Goldfish

The Campbell's Co. is launching a gluten-free version of its popular Goldfish crackers, addressing consumer demand for inclusive snack options. Available in the classic cheddar flavor, Goldfish Gluten Free crackers will hit retailers nationwide in November. This move ensures that more families can enjoy …

CeriBell (NASDAQ:CBLL) Receives "Buy" Rating from BTIG Research

BTIG Research has reaffirmed its "Buy" rating for CeriBell (NASDAQ:CBLL) and maintained a $28 price target, indicating a potential 45% upside from its current price of $19.30. Despite a wider-than-expected Q2 loss of $0.51 per share, the company's revenue exceeded estimates at $28.1 million. …

Rubellite Energy Inc RBY Earnings Beat Estimates by 337.5%

Canaccord raises Ceribell stock price target on strong Q2 results

Canaccord increased its price target for Ceribell (NASDAQ:CBLL) to $26 from $25, maintaining a Buy rating, following strong Q2 fiscal 2026 results. The company reported $28.1 million in revenue, a 33% year-over-year increase, and raised its full-year revenue guidance to $114 million-$117 million. Despite …

Bellway (BWY) Reports 10.8% Increase in Home Completions to 9,695 and £157.7m Net Cash for FY26

BellRing Brands Inc. $BRBR Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its stake in BellRing Brands Inc. (NYSE:BRBR) by 33.9% in the second quarter, selling 455,494 shares and retaining 886,977 shares valued at $11.5 million. Despite institutional investors owning 94.97% of the company, analyst sentiment is mixed, with some …

CeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue Estimates

CeriBell, Inc. (CBLL) reported a Q2 loss of $0.51 per share, missing the Zacks Consensus Estimate of a $0.45 loss, but exceeded revenue estimates with $28.1 million. Despite underperforming the S&P 500 this year, the company's revenue has topped consensus estimates four times in …

CeriBell Lifts 2026 Revenue Forecast on AI EEG Growth, Reports Wider Quarterly Loss

Ceribell has raised its 2026 revenue forecast to $114-$117 million after a 33% increase in Q2 sales, driven by new hospital accounts and higher utilization. Despite strong growth, the GAAP net loss widened by 41% to $19.3 million due to operating expenses rising faster …

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review

Ceribell, Inc. announced FDA 510(k) clearance for two new AI algorithm enhancements for its cloud-based Neurology Portal: Epileptiform Abnormality Detection and Artifact Reduction. These enhancements aim to improve the precision and efficiency of critical-care EEG review by filtering complex background interference and streamlining the …

Half Yearly Results, Half yearly Earnings for Bella Casa Fashion

Saint Bella’s adjusted net profit jumps in first half

CeriBell Inc (CBLL) (Q2 2026) Earnings Call Highlights: Revenue Accelerates 33% on Record ...

CeriBell Inc (CBLL) reported a significant revenue increase of 33% year-over-year to $28.1 million in Q2 2026, driven by strong product and subscription growth. Despite widening net losses due to increased operating expenses and IP litigation costs, the company achieved a record gross margin …

Strong Momentum: Saint Bella Group Issues Interim Positive Profit Alert, with Adjusted Net Profit Expected to Rise by Over 54%

(HUBB) as a Liquidity Pulse for Institutional Tactics

This article analyzes Hubbell Inc (NASDAQ: HUBB), identifying strong sentiment across all time horizons and an overweight bias. AI models have generated three distinct trading strategies for different risk profiles, including position trading, momentum breakout, and risk hedging. The analysis highlights an exceptional risk-reward …

Kimbell Royalty Partners Earnings Call Shows Record Momentum

Key Points Interested in Kimbell Royalty? Here are five stocks we like better. Record second-quarter performance: Kimbell Royalty reported record oil, natural gas and NGL revenue of $103 million, adjusted EBITDA of $84.9 million and average production of 25,830 BOE per day, aided by …

CeriBell Q2 revenue rises 33%, raises FY26 guidance to $114M-$117M

Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings

CeriBell (NASDAQ:CBLL) Releases Earnings Results

Ceribell forecasts FY 2026 revenue of $114 million-$117 million

Ceribell has issued a revenue guidance for FY 2026, projecting $114 million-$117 million. The company reported a 33% year-over-year revenue increase in Q2 2026 and a year-to-date gross margin of 90% as of June 30, 2026. Ceribell estimates a U.S. market opportunity of $3.5 …

Earnings call transcript: Ceribell tops revenue growth in Q2 2026, shares rise

Ceribell reported strong Q2 2026 results, with revenue growing 33% year-over-year to $28.1 million, surpassing expectations despite an EPS miss. The medical-device company's shares rose as investors focused on its continued expansion in seizure detection, record gross margins of 92%, and advancement of new …

Ceribell (Nasdaq: CBLL) grows Q2 2026 revenue 33% but posts larger loss

Ceribell Reports Second Quarter 2026 Financial Results

Ceribell announced strong second-quarter 2026 financial results, with total revenue increasing 33% to $28.1 million driven by new account additions and increased utilization. The company also reported significant milestones, including multiple FDA 510(k) clearances for new algorithms and hardware designs, a new credit facility, …

Ceribell (CBLL) lifts 2026 outlook after 33% Q2 revenue growth to $28.1M